Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03742739
Other study ID # UF 7700
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 29, 2019
Est. completion date August 1, 2021

Study information

Verified date March 2021
Source University Hospital, Montpellier
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

After lung resection surgery, patients usually receive a postoperative pleural drain. Prolongated alveolar air leak (PAAL) is a frequent complication after lung surgery (6 to 26% of patients), defined by the European Society of Thoracic Surgeons (ESTS) as a duration of drainage greater than or equal to five days. PAAL is most often due to prolongated bubbling of the drain. Prolonged drainage is a leading cause of prolongated hospital stay, increasing care costs. The risk of prolongated drainage can not be predicted with sufficient accuracy. Existing risk scores for PAAL do not take into account the intraoperative ventilatory leakage (IVL). IVL is a parameter displayed on the ventilator (anaesthetic machine that make the patient breathing during surgical procedure). There is new evidences suggesting that IVL could predict the risk of PAAL after lung resection surgery, but these data have to be supplemented by a well conducted prospective study.


Recruitment information / eligibility

Status Completed
Enrollment 300
Est. completion date August 1, 2021
Est. primary completion date March 1, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria: - To be 18 years old or older - To be of French nationality or native from an European country affiliated to the French health care system - To be scheduled for pulmonary resection surgery by videothoracoscopy or thoracotomy in the center of the study Exclusion criteria: - Patient minor, or major under legal protection, or enable to give consent - Refusal or consent withdrawal - No pulmonary resection or no pleural drain at the end of the surgical procedure (decided by the surgical team) - Postoperative pleural fistula

Study Design


Related Conditions & MeSH terms

  • Pronlongated Alveolar Air Leak (PAAL)

Locations

Country Name City State
France Department of Anesthesie Reanimation Montpellier

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary PAAL after pulmonary resection surgery End of bubbling is assessed by the nursing team in charge of the patient in accordance with the current practice (no bubbling at forced expiration), and validated by the physician in charge. 5 days after operation
Secondary clinical features Collection of clinical features to identify risk factors for PAAL up to 28 days after the pulmonary resection surgery